JPWO2022253884A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022253884A5 JPWO2022253884A5 JP2023574384A JP2023574384A JPWO2022253884A5 JP WO2022253884 A5 JPWO2022253884 A5 JP WO2022253884A5 JP 2023574384 A JP2023574384 A JP 2023574384A JP 2023574384 A JP2023574384 A JP 2023574384A JP WO2022253884 A5 JPWO2022253884 A5 JP WO2022253884A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- branched alkyl
- straight
- straight chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20210693 | 2021-06-02 | ||
| NO20210693A NO346587B1 (en) | 2021-06-02 | 2021-06-02 | Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis |
| PCT/EP2022/064876 WO2022253884A1 (en) | 2021-06-02 | 2022-06-01 | Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520650A JP2024520650A (ja) | 2024-05-24 |
| JPWO2022253884A5 true JPWO2022253884A5 (enExample) | 2025-05-01 |
Family
ID=82115682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574384A Pending JP2024520650A (ja) | 2021-06-02 | 2022-06-01 | 特発性肺線維症の処置におけるカプサイシン誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240277637A1 (enExample) |
| EP (1) | EP4346789A1 (enExample) |
| JP (1) | JP2024520650A (enExample) |
| CN (1) | CN117412742A (enExample) |
| NO (1) | NO346587B1 (enExample) |
| WO (1) | WO2022253884A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO348880B1 (en) * | 2023-03-13 | 2025-06-30 | Axichem Ab | Physical performance aid |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237423A1 (de) * | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| NO20034069L (no) | 2003-09-12 | 2005-03-14 | Aximed As | Fremstilling og bruk av capsaicinderivater |
| DK2729139T3 (da) * | 2011-07-07 | 2021-02-15 | Eva Millqvist | Hostereducerende produkt |
| WO2015160842A1 (en) * | 2014-04-14 | 2015-10-22 | Flex Pharma, Inc. | Methods and formulatiions of capsaicinoids and capsinoids |
| WO2017160156A1 (en) * | 2016-03-18 | 2017-09-21 | Axichem Ab | Synthetic capasaicin analogs as trpv1 agonists |
| US12428430B2 (en) * | 2018-09-18 | 2025-09-30 | Bristol-Myers Squibb Company | Oxabicyclo acids as LPA antagonists |
| WO2020160225A1 (en) * | 2019-01-30 | 2020-08-06 | Ohio State Innovation Foundation | ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS |
| WO2020191501A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders |
| WO2020227331A1 (en) * | 2019-05-06 | 2020-11-12 | Inspira, LLC | Chemical entities, pharmaceutical formulations, and methods for treating fibrosis |
| CN114026072A (zh) * | 2019-06-25 | 2022-02-08 | 北京泰德制药股份有限公司 | 治疗特发性肺纤维化的方法 |
| NO20200333A1 (en) | 2020-03-20 | 2021-03-29 | Axichem As | Synthesis of capsaicin derivatives |
-
2021
- 2021-06-02 NO NO20210693A patent/NO346587B1/en unknown
-
2022
- 2022-06-01 CN CN202280039778.6A patent/CN117412742A/zh active Pending
- 2022-06-01 EP EP22731584.3A patent/EP4346789A1/en active Pending
- 2022-06-01 WO PCT/EP2022/064876 patent/WO2022253884A1/en not_active Ceased
- 2022-06-01 JP JP2023574384A patent/JP2024520650A/ja active Pending
- 2022-06-01 US US18/564,031 patent/US20240277637A1/en active Pending